Post COVID-19 Condition (NCT05531773)
🩺 Plain-English Summary (8th-Grade Level)
The EuCARE-POSTCOVID study is an observational multicentre study enrolling COVID-19 patients recovered from the acute phase of disease to investigate the prevalence and possible predictors of post COVID-19 condition. The study will retrospectively analyze data already collected at the post COVID-19 outpatients services of the participating centers; furthermore, a prospective cohort study will be performed.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (3 items).
Location: University Hospital Heinrich Heine — Düsseldorf
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- death during hospitalization:
- patient's decline to participate in the study.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (7 Sites)
- University Hospital Heinrich Heine — Düsseldorf,
- Policlinico "Tor Vergata", Università degli Studi di Roma TOR VERGATA — Rome, Lazio
- ASST Santi Paolo e Carlo — Milan, Lombardy
- Vilnius University Hospital, Santaros Klinikos — Vilnius,
- Regional Hospital Dr. Juan Graham Casasús — Villahermosa, Tabasco
- Centro Hospitalar de Lisboa Ocidental — Lisbon,
- St. Mary Hospital, Imperial College Healthcare NHS Trust — London,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.